(Q45764943)

15 December 2017

title

Pooled analysis of safety for micafungin (English)

1 reference

15 December 2017

author name string

OA Cornely

series ordinal

1

1 reference

15 December 2017

P Maddison

series ordinal

2

1 reference

15 December 2017

AJ Ullmann

series ordinal

3

1 reference

15 December 2017

publication date

13 March 2008

1 reference

15 December 2017

published in

Critical Care

1 reference

15 December 2017

volume

12

1 reference

15 December 2017

issue

Suppl 2

1 reference

15 December 2017

page(s)

P21-P21

1 reference

15 December 2017

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088392

PubMed Central

reference URL

retrieved

24 May 2018

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088392

PubMed Central

reference URL

retrieved

24 May 2018

A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088392

PubMed Central

reference URL

retrieved

15 August 2018

Identifiers

DOI

10.1186/CC6242

1 reference

15 December 2017

Dimensions Publication ID

0 references

1 reference

15 December 2017